“Side effects of Vero cell vaccination against Covid-19 among medical students of Nepalgunj Medical College”-A Post Vaccination survey
Preprint
Abstract
Background and aims: Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) is a highly transmissible virus causing Coronavirus disease (COVID-19). Its symptoms include fever, dry cough, and shortness of breath. Vaccine plays a significant role in controlling infectious disease and lesser health resources are used, and there is increased allocation of those resources for disease management. Vero Cell is an inactivated vaccine against COVID-19 manufactured by Sinopharm Company of China and recommended for people above 18 years by the World Health Organization. It is administered in two doses of 0.5 ml, 14-28 days apart. The goal of our study was to determine post-vaccination side effects of both the first(1 st ) and the second(2 nd ) dose among participants of Nepalgunj Medical College Teaching Hospital (NGMCTH), Kohalpur, Banke, Nepal. Methods: A prospective cross-sectional study was conducted among undergraduate medical students and intern doctors of Nepalgunj Medical College. A comprehensive structured questionnaire was designed and distributed following each dose of vaccination. Data were collected from 6 th January 2022 to 6 th April 2022 and entered in Microsoft Excel and analyzed using the statistical package for social sciences (SPSS) version 22. Analyzed data were presented using simple descriptive statistics with appropriate tables. Results: Out of 156 participants, the majority were males (66.7%), within the age group of 21-24. The most frequently encountered symptom was pain at the injection site, predominantly seen in males. Among all the tested variables, the second dose of vaccination showed a significant association with sex. All the predominant symptoms exhibited a significant association following vaccination, except for pain at the injection site (p-value <0.05). Conclusions: Vaccine has proven to be a lifesaving breakthrough during the peak of the COVID-19 outbreak and has been precisely efficacious in a developing country like Nepal.Keywords
This publication has 8 references indexed in Scilit:
- Determinants of associated events following AZD1222 (Covishield) vaccination in a high-risk population in NepalBMC Infectious Diseases, 2022
- Side effects and perceptions following Sinopharm COVID-19 vaccinationInternational Journal of Infectious Diseases, 2021
- Adverse events following Sinopharm (Vero Cell), the inactivated COVID-19Journal of Patan Academy of Health Sciences, 2021
- ChAdOx1 nCoV-19 vaccine and its self-reported adverse events: a cross-sectional study from Western NepalJournal of Global Health Reports, 2021
- Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 VaccinesVaccines, 2021
- From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronavirusesRespiratory Research, 2020
- The first 2019 novel coronavirus case in NepalThe Lancet Infectious Diseases, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020